Literature DB >> 2856943

Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.

G Gebeyehu, V E Marquez, A Van Cott, D A Cooney, J A Kelley, H N Jayaram, G S Ahluwalia, R L Dion, Y A Wilson, D G Johns.   

Abstract

A series of dinucleotides, analogous to nicotinamide adenine dinucleotide but containing the five-membered base nucleosides tiazofurin (1a), selenazofurin (1b), ribavirin (2), and AICAR (3) in place of nicotinamide ribonucleoside, were prepared in greater than 50% yield by reacting the corresponding nucleotide imidazolidates (6a-d) with adenosine 5'-monophosphate (AMP). The symmetric dinucleotides of tiazofurin (TTD, 8e) and selenazofurin (SSD, 8f) were also prepared by a similar methodology. These dinucleotides were characterized by 1H NMR and fast atom bombardment MS and were evaluated for their inhibitory potency against a partially purified preparation of tumoral inosine monophosphate dehydrogenase (IMPD) from P388 cells. The order of potency found was SAD (8b) greater than TAD (8a) much greater than SSD (8f) congruent to TTD (8e) congruent to RAD (8c) much much greater than ZAD (8d). On kinetic analysis none of the dinucleotides produced competitive inhibition of IMPD with NAD as a variable substrate. In addition to their superior IMPD inhibitory activity, SAD and TAD appear to be the only dinucleotides, besides NAD, that are formed naturally by the NAD pyrophosphorylase from P388 lymphoblasts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856943     DOI: 10.1021/jm00379a018

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?

Authors:  Katherine L B Borden; Biljana Culjkovic-Kraljacic
Journal:  Leuk Lymphoma       Date:  2010-10

2.  Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.

Authors:  T D Colby; K Vanderveen; M D Strickler; G D Markham; B M Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.

Authors:  J Balzarini; E De Clercq
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

4.  Ribavirin targets eIF4E dependent Akt survival signaling.

Authors:  Keith Tan; Biljana Culjkovic; Abdellatif Amri; Katherine L B Borden
Journal:  Biochem Biophys Res Commun       Date:  2008-08-14       Impact factor: 3.575

5.  Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity.

Authors:  D F Smee; P A McKernan; L D Nord; R C Willis; C R Petrie; T M Riley; G R Revankar; R K Robins; R A Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses.

Authors:  S K Wray; R H Smith; B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

7.  Design, synthesis and SAR studies of NAD analogues as potent inhibitors towards CD38 NADase.

Authors:  Shengjun Wang; Wenjie Zhu; Xuan Wang; Jianguo Li; Kehui Zhang; Liangren Zhang; Yong-Juan Zhao; Hon Cheung Lee; Lihe Zhang
Journal:  Molecules       Date:  2014-09-29       Impact factor: 4.411

8.  Pathogen induced subversion of NAD+ metabolism mediating host cell death: a target for development of chemotherapeutics.

Authors:  Ayushi Chaurasiya; Swati Garg; Ashish Khanna; Chintam Narayana; Ved Prakash Dwivedi; Nishant Joshi; Zill E Anam; Niharika Singh; Jhalak Singhal; Shikha Kaushik; Amandeep Kaur Kahlon; Pallavi Srivastava; Manisha Marothia; Mukesh Kumar; Santosh Kumar; Geeta Kumari; Akshay Munjal; Sonal Gupta; Preeti Singh; Soumya Pati; Gobardhan Das; Ram Sagar; Anand Ranganathan; Shailja Singh
Journal:  Cell Death Discov       Date:  2021-01-13

Review 9.  Selenium and selenoproteins: it's role in regulation of inflammation.

Authors:  Sneha Hariharan; Selvakumar Dharmaraj
Journal:  Inflammopharmacology       Date:  2020-03-06       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.